Cargando…

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullmann, Andrew J., Schmidt-Hieber, Martin, Bertz, Hartmut, Heinz, Werner J., Kiehl, Michael, Krüger, William, Mousset, Sabine, Neuburger, Stefan, Neumann, Silke, Penack, Olaf, Silling, Gerda, Vehreschild, Jörg Janne, Einsele, Hermann, Maschmeyer, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972852/
https://www.ncbi.nlm.nih.gov/pubmed/27339055
http://dx.doi.org/10.1007/s00277-016-2711-1
_version_ 1782446303932841984
author Ullmann, Andrew J.
Schmidt-Hieber, Martin
Bertz, Hartmut
Heinz, Werner J.
Kiehl, Michael
Krüger, William
Mousset, Sabine
Neuburger, Stefan
Neumann, Silke
Penack, Olaf
Silling, Gerda
Vehreschild, Jörg Janne
Einsele, Hermann
Maschmeyer, Georg
author_facet Ullmann, Andrew J.
Schmidt-Hieber, Martin
Bertz, Hartmut
Heinz, Werner J.
Kiehl, Michael
Krüger, William
Mousset, Sabine
Neuburger, Stefan
Neumann, Silke
Penack, Olaf
Silling, Gerda
Vehreschild, Jörg Janne
Einsele, Hermann
Maschmeyer, Georg
author_sort Ullmann, Andrew J.
collection PubMed
description Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared a preliminary guideline, which was discussed, reviewed, and approved by the entire working group. The guideline provides clinical recommendations for the preventive management including prophylactic treatment of viral, bacterial, parasitic, and fungal diseases. The guideline focuses on antimicrobial agents but includes recommendations on the use of vaccinations. This is the updated version of the AGHIO guideline in the field of allogeneic haematopoietic stem cell transplantation utilizing methods according to evidence-based medicine criteria.
format Online
Article
Text
id pubmed-4972852
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49728522016-08-17 Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 Ullmann, Andrew J. Schmidt-Hieber, Martin Bertz, Hartmut Heinz, Werner J. Kiehl, Michael Krüger, William Mousset, Sabine Neuburger, Stefan Neumann, Silke Penack, Olaf Silling, Gerda Vehreschild, Jörg Janne Einsele, Hermann Maschmeyer, Georg Ann Hematol Original Article Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared a preliminary guideline, which was discussed, reviewed, and approved by the entire working group. The guideline provides clinical recommendations for the preventive management including prophylactic treatment of viral, bacterial, parasitic, and fungal diseases. The guideline focuses on antimicrobial agents but includes recommendations on the use of vaccinations. This is the updated version of the AGHIO guideline in the field of allogeneic haematopoietic stem cell transplantation utilizing methods according to evidence-based medicine criteria. Springer Berlin Heidelberg 2016-06-24 2016 /pmc/articles/PMC4972852/ /pubmed/27339055 http://dx.doi.org/10.1007/s00277-016-2711-1 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Ullmann, Andrew J.
Schmidt-Hieber, Martin
Bertz, Hartmut
Heinz, Werner J.
Kiehl, Michael
Krüger, William
Mousset, Sabine
Neuburger, Stefan
Neumann, Silke
Penack, Olaf
Silling, Gerda
Vehreschild, Jörg Janne
Einsele, Hermann
Maschmeyer, Georg
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title_full Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title_fullStr Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title_full_unstemmed Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title_short Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
title_sort infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972852/
https://www.ncbi.nlm.nih.gov/pubmed/27339055
http://dx.doi.org/10.1007/s00277-016-2711-1
work_keys_str_mv AT ullmannandrewj infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT schmidthiebermartin infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT bertzhartmut infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT heinzwernerj infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT kiehlmichael infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT krugerwilliam infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT moussetsabine infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT neuburgerstefan infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT neumannsilke infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT penackolaf infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT sillinggerda infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT vehreschildjorgjanne infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT einselehermann infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT maschmeyergeorg infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016
AT infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016